da Rocha, Lucas R.
Costa, Gabriel P.A.
Sofuoglu, Mehmet
Castaldelli-Maia, João Mauricio
De Aquino, Joao P. https://orcid.org/0000-0001-7357-8215
Funding for this research was provided by:
VA VISN 1 Mental Illness, Research, Education, and Clinical Center
National Institute on Drug Abuse (K23 DA052682, R21 DA057240, R01 DA600066, and RM1 DA0554310)
Article History
Received: 18 July 2025
Accepted: 19 September 2025
First Online: 14 October 2025
Declarations
:
: Dr. De Aquino has been supported in clinical trials by Jazz Pharmaceuticals and Ananda Scientific, specifically through medication provisions. Additionally, Dr. De Aquino has been a compensated consultant for Boehringer Ingelheim.
: No animal or human subjects by the authors were used in this study.